21.35
-0.0091(-0.04%)
Currency In USD
| Previous Close | 21.36 |
| Open | 21.36 |
| Day High | 21.39 |
| Day Low | 21.32 |
| 52-Week High | 23.57 |
| 52-Week Low | 6.38 |
| Volume | 2.33M |
| Average Volume | 2.9M |
| Market Cap | 2.06B |
| PE | -1,067.54 |
| EPS | -0.02 |
| Moving Average 50 Days | 18.24 |
| Moving Average 200 Days | 12.25 |
| Change | -0.01 |
If you invested $1000 in Avadel Pharmaceuticals plc (AVDL) 10 years ago, it would be worth $1,431.03 as of December 04, 2025 at a share price of $21.351. Whereas If you bought $1000 worth of Avadel Pharmaceuticals plc (AVDL) shares 5 years ago, it would be worth $3,058.87 as of December 04, 2025 at a share price of $21.351.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
GlobeNewswire Inc.
Yesterday at 9:47 PM GMT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT MADE UNDER RULE 17(B) (AS
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
GlobeNewswire Inc.
Dec 01, 2025 9:05 PM GMT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT MADE UNDER RULE 17(A) (AS
Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”
GlobeNewswire Inc.
Nov 17, 2025 10:45 AM GMT
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUT